VEGF and TGF-beta Are Required for the Maintenance of the Choroid Plexus and Ependyma

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2008 Feb 13

PMID 18268040

Citations 79

Authors

Arindel S R Maharaj

Tony E Walshe

Magali Saint-Geniez

Shivalingappa Venkatesha

Angel E Maldonado

Nathan C Himes

Kabir S Matharu

S Ananth Karumanchi

Patricia A DAmore

Affiliations

Soon will be listed here.

Abstract

Although the role of vascular endothelial growth factor (VEGF) in developmental and pathological angiogenesis is well established, its function in the adult is less clear. Similarly, although transforming growth factor (TGF) beta is involved in angiogenesis, presumably by mediating capillary (endothelial cell [EC]) stability, its involvement in quiescent vasculature is virtually uninvestigated. Given the neurological findings in patients treated with VEGF-neutralizing therapy (bevacizumab) and in patients with severe preeclampsia, which is mediated by soluble VEGF receptor 1/soluble Fms-like tyrosine kinase receptor 1 and soluble endoglin, a TGF-beta signaling inhibitor, we investigated the roles of VEGF and TGF-beta in choroid plexus (CP) integrity and function in adult mice. Receptors for VEGF and TGF-beta were detected in adult CP, as well as on ependymal cells. Inhibition of VEGF led to decreased CP vascular perfusion, which was associated with fibrin deposition. Simultaneous blockade of VEGF and TGF-beta resulted in the loss of fenestrae on CP vasculature and thickening of the otherwise attenuated capillary endothelium, as well as the disappearance of ependymal cell microvilli and the development of periventricular edema. These results provide compelling evidence that both VEGF and TGF-beta are involved in the regulation of EC stability, ependymal cell function, and periventricular permeability.

Citing Articles

Aberrant choroid plexus formation drives the development of treatment-related brain toxicity.

Bender T, Schickel E, Schielke C, Debus J, Grosshans D, Durante M Commun Biol. 2025; 8(1):276.

PMID: 39987290 PMC: 11846864. DOI: 10.1038/s42003-025-07736-2.

Aging alters the expression of trophic factors and tight junction proteins in the mouse choroid plexus.

Sadanandan J, Sathyanesan M, Newton S Fluids Barriers CNS. 2024; 21(1):77.

PMID: 39334352 PMC: 11438291. DOI: 10.1186/s12987-024-00574-0.

Enhanced Brain Clearance of Tau and Amyloid-β in Alzheimer's Disease Patients by Transcranial Radiofrequency Wave Treatment: A Central Role of Vascular Endothelial Growth Factor (VEGF).

Arendash G, Lin X, Cao C J Alzheimers Dis. 2024; 100(s1):S223-S241.

PMID: 39177605 PMC: 11380279. DOI: 10.3233/JAD-240600.

Case report: heart failure related to intravitreal injection of anti-VEGF.

Sui Y, Zhao Y, Zhou N, Sun H, Sun Y, Liu J BMC Cardiovasc Disord. 2024; 24(1):418.

PMID: 39135154 PMC: 11318321. DOI: 10.1186/s12872-024-04095-4.

Disruption of maternal vascular remodeling by a fetal endoretrovirus-derived gene in preeclampsia.

Gong X, He W, Jin W, Ma H, Wang G, Li J Genome Biol. 2024; 25(1):117.

PMID: 38715110 PMC: 11075363. DOI: 10.1186/s13059-024-03265-z.

References

Ogawa M, Shiozawa M, Hiraoka Y, Takeuchi Y, Aiso S . Immunohistochemical study of localization of gamma-glutamyl transpeptidase in the rat brain. Tissue Cell. 1999; 30(6):597-601. DOI: 10.1016/s0040-8166(98)80078-5. View

Stopa E, Berzin T, Kim S, Song P, Baird A, Johanson C . Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?. Exp Neurol. 2001; 167(1):40-7. DOI: 10.1006/exnr.2000.7545. View

Miquerol L, Langille B, Nagy A . Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000; 127(18):3941-6. DOI: 10.1242/dev.127.18.3941. View

Adamis A, Shima D . The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005; 25(2):111-8. DOI: 10.1097/00006982-200502000-00001. View

Maharaj A, Saint-Geniez M, Maldonado A, DAmore P . Vascular endothelial growth factor localization in the adult. Am J Pathol. 2006; 168(2):639-48. PMC: 1606504. DOI: 10.2353/ajpath.2006.050834. View

Gupta S . Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol. 2002; 22(1):15-20. View

Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W . Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol. 1998; 140(4):947-59. PMC: 2141756. DOI: 10.1083/jcb.140.4.947. View

Glusker P, Recht L, Lane B . Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006; 354(9):980-2. DOI: 10.1056/NEJMc052954. View

Runge V, Muroff L, Wells J . Principles of contrast enhancement in the evaluation of brain diseases: an overview. J Magn Reson Imaging. 1997; 7(1):5-13. DOI: 10.1002/jmri.1880070103. View

10.

Sibai B, Dekker G, Kupferminc M . Pre-eclampsia. Lancet. 2005; 365(9461):785-99. DOI: 10.1016/S0140-6736(05)17987-2. View

11.

Schanzer A, Wachs F, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H . Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 2004; 14(3):237-48. PMC: 8096047. DOI: 10.1111/j.1750-3639.2004.tb00060.x. View

12.

Watabe T, Nishihara A, Mishima K, Yamashita J, Shimizu K, Miyazawa K . TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol. 2003; 163(6):1303-11. PMC: 2173713. DOI: 10.1083/jcb.200305147. View

13.

Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P . Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol. 2004; 165(1):35-52. PMC: 1618540. DOI: 10.1016/S0002-9440(10)63273-7. View

14.

Bian Z, Elner S, Elner V . Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res. 2007; 84(5):812-22. PMC: 2094015. DOI: 10.1016/j.exer.2006.12.016. View

15.

Loureiro R, DAmore P . Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev. 2005; 16(1):77-89. DOI: 10.1016/j.cytogfr.2005.01.005. View

16.

Kim H, Hwang K, Seo J, Kim S, Oh B, Lee M . Apoptosis and regulation of Bax and Bcl-X proteins during human neonatal vascular remodeling. Arterioscler Thromb Vasc Biol. 2000; 20(4):957-63. DOI: 10.1161/01.atv.20.4.957. View

17.

Stan R, Kubitza M, Palade G . PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci U S A. 1999; 96(23):13203-7. PMC: 23925. DOI: 10.1073/pnas.96.23.13203. View

18.

Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund S . VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003; 34(4):383-94. DOI: 10.1038/ng1211. View

19.

Sandler A, Gray R, Perry M, Brahmer J, Schiller J, Dowlati A . Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006; 355(24):2542-50. DOI: 10.1056/NEJMoa061884. View

20.

Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004; 350(23):2335-42. DOI: 10.1056/NEJMoa032691. View